Moving Mountains for Multiple Myeloma Receives the Bell Ringer Award

The award honors the collaborative efforts of CURE Media Group, Multiple Myeloma Research Foundation and Takeda

CRANBURY, N.J.--()--Moving Mountains for Multiple Myeloma (MM4MM), an initiative by CURE Media Group, Multiple Myeloma Research Foundation and Takeda was honored with the prestigious Bell Ringer award at the 49th Annual Bell Ringer Award ceremony, held on June 1, 2017. The award recognizes the efforts put forward by all three organizations to inspire, empower and engage the multiple myeloma community.

The award presented under the Cause Marketing Campaign category credits the MM4MM project that takes patients, caregivers, doctors, nurses and loved ones on challenging mountain climbs. Each climb signifies the developments and improvements made in the treatment and research of multiple myeloma. Recent hikes have taken teams to adventurous journeys through Machu Picchu, Grand Canyon, Mount Kilimanjaro and Mt. Fuji coming up in July, collectively raising over $1 million.

The Publicity Club of New England’s Bell Ringer Awards honor the exceptional achievements by the communications and public relations teams from various industries. The awards recognize experts whose creative and unique strategies achieve significant results for the companies, clients and institutions.

About the Multiple Myeloma Research Foundation (MMRF)

The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts.

Since its inception, the organization has raised over $330 million and directs nearly 90 percent of the total funds to research and related programs. The MMRF has received the "Best in America" Seal of Excellence from the Independent Charities of America and Charity Navigator's 4-star rating for twelve years. The MMRF has also been recognized by Philanthropedia as one of 16 expert-identified, high-impact nonprofits in the field of cancer. To learn more, visit http://www.themmrf.org.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit http://www.curetoday.com or http://www.mjhassoc.com.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, visit http://www.takeda.com/news.

Additional information about Takeda is available through its corporate website, www.takeda.com, and additional information about Takeda Oncology, the brand for the global oncology business unit of Takeda Pharmaceutical Company Limited, is available through its website, www.takedaoncology.com.

Contacts

CURE Media Group Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com

Release Summary

Moving Mountains for Multiple Myeloma Receives the Bell Ringer Award

#Hashtags

Contacts

CURE Media Group Press:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com